A Trial Testing Amiodarone in Chagas Cardiomiopathy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
Purpose: The ATTACH trial, as currently designed, will primarily test whether a treatment with Amiodarone for at least 6 months has a trypanocidal effect among individuals with mild-to-moderate Chronic Chagas Cardiomyopathy. A secondary goal will be to confirm, in this population, a clinical benefit from this treatment (in terms of reducing mortality or cardiac arrhythmic events), and to explore whether a potential trypanocidal effect is associated with a clinical benefit.
Epistemonikos ID: 33ab2f46c3f80083285e2f26f5b0336992e634e5
First added on: May 20, 2024